Scholar Rock
SRRK · NASDAQ
Bulios Fair Price
$44.76
9.3% downside
Current Price
$49.37
According to Bulios Fair Price, SRRK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Scholar Rock Holding Corporation is a U.S.-based biotechnology company focused on developing therapeutics that specialize in innovative approaches to modulating biological signaling pathways. The company concentrates on developing drugs that target proteins and signaling molecules involved in cell growth and development, particularly in the fields of neurology, oncology, and immunology. Scholar Rock is positioned as a leader in highly targeted therapies with the potential to transform the treatment of a range of serious and previously difficult-to-treat diseases.
Sector
Healthcare
Industry
Biotechnology
CEO
David L. Hallal
Employees
289
Headquarters
Cambridge
Upcoming events
Earnings
Upcoming earnings report